Shares of Cerner Co. (NASDAQ:CERN) have been assigned a consensus rating of “Hold” from the twenty-three research firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $66.18.
A number of equities research analysts have recently commented on the stock. Argus cut shares of Cerner from a “buy” rating to a “hold” rating and increased their price target for the company from $54.49 to $64.65 in a report on Tuesday. Stifel Nicolaus reiterated a “hold” rating and set a $71.00 price target (up previously from $69.00) on shares of Cerner in a report on Thursday, March 8th. BidaskClub upgraded shares of Cerner from a “strong sell” rating to a “sell” rating in a report on Thursday, March 8th. Cantor Fitzgerald reiterated a “buy” rating and set a $80.00 price target on shares of Cerner in a report on Monday, March 5th. Finally, Bank of America assumed coverage on shares of Cerner in a report on Tuesday, February 27th. They set a “buy” rating and a $75.00 price target on the stock.
In related news, VP Jeffrey A. Townsend sold 230,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total value of $14,246,200.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William D. Zollars sold 4,100 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The disclosure for this sale can be found here. Insiders sold 541,800 shares of company stock worth $34,353,860 in the last 90 days. 13.11% of the stock is currently owned by corporate insiders.
Cerner (CERN) opened at $63.05 on Wednesday. Cerner has a one year low of $54.49 and a one year high of $73.86. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11. The firm has a market cap of $21,499.09, a P/E ratio of 29.12, a price-to-earnings-growth ratio of 1.88 and a beta of 0.93.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing the Zacks’ consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the company earned $0.61 EPS. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. equities research analysts expect that Cerner will post 2.42 EPS for the current fiscal year.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.